Evaluating Ivosidenib for the Treatment of Relapsed/Refractory aml: Design, Development, and Place in Therapy
Document Type
Journal Article
Publication Date
2019
Journal
OncoTargets and Therapy
Volume
12
Inclusive Pages
303-308
DOI
10.2147/OTT.S182443
APA Citation
Nassereddine, S., Lap, C., & Tabbara, I. A. (2019). Evaluating Ivosidenib for the Treatment of Relapsed/Refractory aml: Design, Development, and Place in Therapy. OncoTargets and Therapy, 12 (). http://dx.doi.org/10.2147/OTT.S182443
Peer Reviewed
1
Open Access
1
COinS